Abstract:Crohn's disease is a chronic idiopathic inflammatory disease that may involve any part of the gastrointestinal tract from the mouth to the anus. It most commonly affects the terminal ileum and cecum, and less commonly is isolated to the colon. Crohn's disease involving the stomach or duodenum is uncommon and described in only 0.5% to 4% of patients.1Ibrahim S.H. Smyrk T.C. Faubion W.A. Treatment of isolated gastric Crohn's disease with inhaled corticosteroids.Case Rep Gastroenterol. 2008; 2: 363-368Crossref PubMed Google Scholar A 17-year-old girl was referred to our hospital with a 6-year history of intermittent abdominal pain and vomiting, which worsened during the recent 2 months with a 3-kg weight loss. She had no history of abdominal surgery or trauma, and denied chronic hepatitis virus infection or any use of nonsteroidal anti-inflammatory drugs. She had undergone gastroscopy examination at the local hospital and was diagnosed with nonatrophic gastritis with gastric outlet obstruction. She was treated with antibiotics and antacids, but without significant relief. On admission, the patient was unable to tolerate oral intake other than minimal amounts of water, and physical examination revealed mild tenderness of the upper abdominal quadrant. Laboratory blood analyses including serum tumor markers, adenosine deaminase activity, and anti-tuberculosis antibody were all within normal limits, whereas erythrocyte sedimentation rate (22 mm/h, normal range, 0-15 mm/h), lymphocyte ratio (59.5%, normal range, 20%-50%), and free fatty acids (107.0 μmol/d, normal range, 10.0-85.0 μmol/d) were elevated. Her stool microscopy was positive for occult blood but negative for ova, cysts, or parasites. Upper gastrointestinal study with Gastrografin (Bracco Diagnostic Inc, Monroe Township, NJ) revealed irregularity of the distal antrum in the prepyloric region and marked narrowing of the pylorus, duodenal bulb, and postbulbar duodenum (Figure 1). In addition, diffuse cobblestone mucosal changes were present throughout the body of the stomach, and a bamboo joint-like appearance of the gastric body (Figure 2) was detected. The contrast-enhanced computed tomography (CT) scan showed multiple projections with slight enhancement along the gastric walls (Figure 3A-C), as well as slight enhancement and thickening of the pylorus (Figure 3D-F). Endoscopic ultrasound showed focal thickening of the gastric mucosal and submucosal layers with hypoechoic layer (Figure 4A). In addition, endoscopic ultrasound demonstrated significant circumferential thickening of the pylorus without normal stratification of the walls (Figure 4B).Figure 2Diffuse cobblestone mucosal change was present throughout the body of the stomach, and a bamboo joint-like appearance (arrow) of the gastric body was detected on radiography.View Large Image Figure ViewerDownload Hi-res image Download (PPT)Figure 3The transaxial, coronal, and sagittal cross-sectional contrast-enhanced CT scan showed multiple projections with slight enhancement along the gastric walls (A-C, arrow), as well as slight enhancement and thickening of the pylorus (D-F, arrow).View Large Image Figure ViewerDownload Hi-res image Download (PPT)Figure 4Endoscopic ultrasound showed focal thickening of the gastric mucosal and submucosal layers with hypoechoic layer (A, arrow); endoscopic ultrasound demonstrated significant circumferential thickening of the pylorus without normal stratification of the walls (B, arrow).View Large Image Figure ViewerDownload Hi-res image Download (PPT) The patient underwent esophagogastroduodenoscopy examination, which revealed erythema (Figure 5A), longitudinal ulcers (Figure 5A), and cobblestone-like lesions in the gastric body. In addition, esophagogastroduodenoscopy also showed mucosal edema, erosion, and narrowing of the pyloric antrum (Figure 5B). Histopathologic examination of biopsies from involved areas in the stomach demonstrated nonspecific acute and chronic inflammation with massive neutrophil and lymphocyte infiltration (Figure 5C), and acid-fast staining did not reveal any acid-fast bacilli. These results were compatible with the previous biopsy samples of the stomach, which did not detect granulomas, malignancy, caseation, or tubercle bacilli. To evaluate the extent of the disease and provide important diagnostic clues, ileocolonoscopy was performed, which demonstrated areas of polypoid hyperplasia in the terminal ileum (Figure 5D), whereas the colon and rectum were normal (Figure 5E). Histopathologic examination of biopsies from terminal ileum showed granuloma, superficial small ulcers, and chronic inflammatory cell infiltration (Figure 5F). The diagnosis of Crohn's disease involving the stomach and ileum was confirmed for this patient. The diagnosis of Crohn's disease, especially gastric Crohn's disease, sometimes can be challenging because the incidence of gastroduodenal involvement in Crohn's disease is extremely low. Therefore, a high degree of clinical suspicion often is required to assist the physician in making the diagnosis. A definitive diagnosis of gastric Crohn's disease traditionally has relied on the histopathologic demonstration of noncaseating granulomas; however, the prevalence of granulomas in gastroduodenal biopsies tends to be low, and granuloma can be detected in less than 20% of the patients, whereas nonspecific gastric inflammation or focally enhanced gastritis was the most common finding.2Diaz L. Hernandez-Oquet R.E. Deshpande A.R. Moshiree B. Upper gastrointestinal involvement in Crohn disease: histopathologic and endoscopic findings.South Med J. 2015; 108: 695-700Crossref PubMed Scopus (24) Google Scholar Because mucosal biopsies are not likely to demonstrate the transmural nature of Crohn's disease, even multiple or repeat biopsies may not result in higher rates of granuloma discovery3Wagtmans M.J. Verspaget H.W. Lamers C.B. et al.Clinical aspects of Crohn's disease of the upper gastrointestinal tract: a comparison with distal Crohn's disease.Am J Gastroenterol. 1997; 92: 1467-1471PubMed Google Scholar; therefore, endoscopic ultrasound might play a valuable role in evaluation of the disease. A lack of specificity for pathologic findings in patients with gastric Crohn's disease makes it difficult to be differentiated from Helicobacter pylori infection, tuberculosis, nonsteroidal anti-inflammatory drugs gastritis, Menetrier's disease, gastrinoma, collagen vascular disease, and lymphoma.4Ingle S.B. Hinge C.R. Dakhure S. et al.Isolated gastric Crohn's disease.World J Clin Cases. 2013; 1: 71-73Crossref PubMed Google Scholar When tissue diagnosis is not conclusive, diagnosis should be considered on the basis of clinical, laboratory, endoscopic, and radiologic findings. The typical radiologic or endoscopic findings, such as strictures, longitudinal ulcerations, cobblestone lesions, erythema, and erosions, were all detected in the present case and highly suggestive of the diagnosis of gastric Crohn's disease. Of note, radiography also revealed the bamboo joint-like appearance of the gastric body, which is characterized by swollen longitudinal folds transversed by erosive fissures or linear furrows at the gastric body and cardia.5Hashiguchi K. Takeshima F. Akazawa Y. et al.Bamboo joint-like appearance of the stomach: a stable endoscopic landmark for Crohn's disease regardless of anti-tumor necrosis factor alpha treatment.Med Sci Monit. 2014; 20: 1918-1924Crossref PubMed Scopus (7) Google Scholar, 6Yokota K. Saito Y. Einami K. et al.A bamboo joint-like appearance of the gastric body and cardia: possible association with Crohn's disease.Gastrointest Endosc. 1997; 46: 268-272Abstract Full Text Full Text PDF PubMed Scopus (36) Google Scholar The bamboo joint-like appearance is reported as a characteristic and stable endoscopic landmark of gastric Crohn's disease and remains unchanged in both remission and active stages.5Hashiguchi K. Takeshima F. Akazawa Y. et al.Bamboo joint-like appearance of the stomach: a stable endoscopic landmark for Crohn's disease regardless of anti-tumor necrosis factor alpha treatment.Med Sci Monit. 2014; 20: 1918-1924Crossref PubMed Scopus (7) Google Scholar, 6Yokota K. Saito Y. Einami K. et al.A bamboo joint-like appearance of the gastric body and cardia: possible association with Crohn's disease.Gastrointest Endosc. 1997; 46: 268-272Abstract Full Text Full Text PDF PubMed Scopus (36) Google Scholar Although Gastrografin is limited in evaluating mucosal details or abnormalities and barium has superior physical properties of mucosal coating and radiographic density, in this study Gastrografin was still used instead of barium in radiography for fear of exacerbating the gastric outlet obstruction. Delayed elimination of barium from the body will delay further examination of the CT scan and endoscopy. In addition, despite esophagogastroduodenoscopy, ileocolonoscopy also is recommended for gastric Crohn's disease. The typical findings in terminal ileum, cecum, or colon not only contribute to accurate evaluation of the extent of the disease but also provide important diagnostic clues. Recently, serologic testing of anti-Saccharomyces cerevisiae antibody and perinuclear anti-neutrophil cytoplasmic antibody is reported to play an important role in the diagnosis of atypical Crohn's disease with high specificity.4Ingle S.B. Hinge C.R. Dakhure S. et al.Isolated gastric Crohn's disease.World J Clin Cases. 2013; 1: 71-73Crossref PubMed Google Scholar In the future, gene tests, such as NOD2/CARD15 gene mutations, also might be used to support the diagnosis of gastroduodenal Crohn's disease.4Ingle S.B. Hinge C.R. Dakhure S. et al.Isolated gastric Crohn's disease.World J Clin Cases. 2013; 1: 71-73Crossref PubMed Google Scholar, 7Naser S.A. Arce M. Khaja A. et al.Role of ATG16L, NOD2 and IL23R in Crohn's disease pathogenesis.World J Gastroenterol. 2012; 18: 412-424Crossref PubMed Scopus (80) Google Scholar No controlled, prospective studies on the treatment of gastroduodenal Crohn's disease have been reported. Because the course of Crohn's disease is chronic and most commonly characterized with periods of relapses and remissions, treatment is focused on relieving the symptoms and putting it into remission.8Shimoyama Y. Kusano M. Hirano Y. et al.Onset of gastric Crohn's disease observed endoscopically.Gastrointest Endosc. 2010; 72: 1060-1061Abstract Full Text Full Text PDF PubMed Scopus (2) Google Scholar Proton pump inhibitors in combination with steroids are the first line of treatment in active Crohn's disease. 6-Mercaptopurine and azathioprine have been shown to maintain corticosteroid-induced remission and should be instituted early in the disease course.9Kefalas C.H. Gastroduodenal Crohn's disease.BUMC Proc. 2003; 16: 147-151Google Scholar Anti-tumor necrosis factor α therapy, such as infliximab, has recently changed the treatment paradigm and become an important addition to the therapeutic options in steroid-refractory Crohn's disease. Hashiguchi et al5Hashiguchi K. Takeshima F. Akazawa Y. et al.Bamboo joint-like appearance of the stomach: a stable endoscopic landmark for Crohn's disease regardless of anti-tumor necrosis factor alpha treatment.Med Sci Monit. 2014; 20: 1918-1924Crossref PubMed Scopus (7) Google Scholar reported that infliximab can not only induce rapid and sustained mucosal healing but also contribute to fistula closure, thereby changing the natural history of Crohn's disease.5Hashiguchi K. Takeshima F. Akazawa Y. et al.Bamboo joint-like appearance of the stomach: a stable endoscopic landmark for Crohn's disease regardless of anti-tumor necrosis factor alpha treatment.Med Sci Monit. 2014; 20: 1918-1924Crossref PubMed Scopus (7) Google Scholar However, the role of infliximab in treating gastric Crohn's disease has scarcely been studied, and the effectiveness and long-term outcome need further study.4Ingle S.B. Hinge C.R. Dakhure S. et al.Isolated gastric Crohn's disease.World J Clin Cases. 2013; 1: 71-73Crossref PubMed Google Scholar In this patient, the symptoms improved greatly after receiving nutritional supplement and proton pump inhibitors treatment. The patient was discharged and recommended steroid and azathioprine therapy. The patient responded nicely and has remained clinically asymptomatic during 2 months of follow-up. Although medical therapies usually afford symptom relief, the end result often is surgical resection because of progression to medically refractory disease or disease-related complications, such as fistulas, massive bleeding, or outlet obstructions. Surgery is not curative for Crohn's disease, and clinical recurrence can be as high as 40% within 1 year of surgery in those not receiving any prophylaxis.10Nguyen G.C. Loftus Jr., E.V. Hirano I. et al.American Gastroenterological Institute Guideline on the Management of Crohn's Disease After Surgical Resection.Gastroenterology. 2017; 152: 271-275Abstract Full Text Full Text PDF PubMed Scopus (120) Google Scholar The latest American Gastroenterological Institute Guideline on the management of Crohn's disease after surgical resection recommends early prophylactic use of thiopurines or anti-tumor necrosis factor therapy in patients who are at higher risk for clinical recurrence, whereas patients at lower risk may opt for close endoscopic monitoring instead.11Regueiro M. Velayos F. Greer J.B. et al.American Gastroenterological Association Technical Review on the Management of Crohn's Disease After Surgical Resection.Gastroenterology. 2017; 152: 277-295e3Abstract Full Text Full Text PDF PubMed Scopus (83) Google Scholar However, this guideline is developed on the basis of data from patients with ileocolic Crohn's disease. Although no studies on patients with gastric Crohn's disease were available to inform this recommendation, follow-up with endoscopic monitoring is needed not only for evaluation of mucosa healing and treatment responses, thereby paving the way to standardized guidelines in the diagnosis and treatment approach for gastric Crohn's disease,2Diaz L. Hernandez-Oquet R.E. Deshpande A.R. Moshiree B. Upper gastrointestinal involvement in Crohn disease: histopathologic and endoscopic findings.South Med J. 2015; 108: 695-700Crossref PubMed Scopus (24) Google Scholar but also for early detection of gastric cancer as a possible association between gastric malignancy and long-standing gastric Crohn's disease has been reported.12Estlein D. Ohana G. Weil R. et al.Early cancer in gastric Crohn's disease.Isr Med Assoc J. 2001; 3: 379-380PubMed Google Scholar

Abstract:To the Editor: Ulcerative colitis (UC) is traditionally known to be confined to the large bowel. The presence of upper gastrointestinal (GI) involvement has long been considered as a sign of Crohn disease (CD) rather than UC. However, involvement of the upper GI and small intestine has previously been reported in UC.[1,2] Importantly, both the symptoms and endoscopic features easily lead to a misdiagnosis of acute erosive or infectious gastroduodenitis. The present case highlights the need to consider upper GI involvement of UC as a differential diagnosis. This case may prompt physician to recognize the possibility of an adult-onset UC subtype involving the upper GI; to consider whether upper GI involvement should be classified as a special and rare type of UC like CD, suggesting that it may be a high-risk factor for active disease or poor prognosis; and to determine whether more aggressive treatment are needed for patients with this kind of condition. A 24-year-old woman was diagnosed with UC with left-sided colonic involvement at the age of 22. Disease remission was achieved with oral mesalamine, which she elected to discontinue after 1 year because she felt well. Eleven months later, she experienced recurrent bloody diarrhea, together with abdominal pain and significant nausea and vomiting. On presentation to the emergency department, she was afebrile and not tachycardic; however, tenderness was noted on palpation of the epigastrium and left lower abdomen. Laboratory tests showed elevated inflammatory marker level (C-reactive protein 86 mg/dL), mild anemia (hemoglobin 10.6 g/dL) and hypoalbuminemia (albumin 29.2 g/L). A non-contrast computed tomography (CT) scan unexpectedly showed diffuse gastroduodenitis, in addition to continuous colitis [Figure 1A]. She had not taken any drugs, including non-steroidal anti-inflammatory drugs in the last 11 months. Infectious causes including Clostridium difficile, Epstein-Barr virus (EBV), and cytomegalovirus (CMV) were ruled out. She was treated with full-dose oral and topical mesalamine, intravenous proton pump inhibitor, and empiric antibiotics.Figure 1: (A) Non-contrast CT showed gastroduodenitis and colitis. (B–D) EGD revealed diffuse gastroduodenitis with multiple small fibrin-covered erosions in the stomach and duodenum. (E–G) Colonoscopy showed continuous and confluent coarse granular appearance with erosions, mucosal friability, and complete loss of vascular pattern. (H–J) Pathologic examination showed crypt abscess, crypt abnormalities with distortion, mucosal atrophy, and plasma cell infiltrates in the lamina propria, which were diffuse in colon (original magnification, ×100). (K–M) Pathologic examination showed crypt abnormalities with distortion, mucosal atrophy, plasma cell infiltrates in the lamina propria, and clusters of neutrophils, which were diffuse in upper GI ([K and M] original magnification, ×200; [L] original magnification, ×100). (N) Abdominal CT scan taken after 5 days of steroid treatment showed that the gastroduodenal inflammation had considerably improved. (O–Q) EGD performed after a course of steroid treatment showed improvement of the inflammation, although the chronic diffuse coarse granular appearance remained. (R–S) Pathologic examination of gastroduodenum performed after a course of steroid treatment showed abnormal crypts with distortion, atrophic mucosa, and decreased plasma cell infiltration in the lamina propia (original magnification, ×200). CT: Computed tomography; EGD: Esophagogastroduodenoscopy.However, her nausea and vomiting worsened. Esophagogastroduodenoscopy revealed diffuse gastroduodenitis with multiple small fibrin-covered erosions in the stomach and duodenum [Figure 1B–D], which closely resembled the UC lesion on colonoscopy [Figure 1E–G]. The pathology of colon [Figure 1H–J] and upper GI tract [Figure 1K–M] were diagnosed with colonic UC and UC with upper GI involvement, respectively, as they showed negative staining for Helicobacter pylori, CMV and EBV; no evidence of granulomas which might suggest CD; and no features resembling erosive gastroduodenitis. The diagnosis of UC was further confirmed by serologic tests for perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) positive and anti-Saccharomyces cerevisiae antibody negative, as well as by capsule enteroscopy, which demonstrated normal ileal and jejunal mucosa. Intravenous methylprednisolone 60 mg once daily was commenced, with complete resolution of all symptoms within 3 days. Abdominal CT was repeated after 5 days of treatment which showed that the gastroduodenal inflammation had considerably improved [Figure 1N]. The patient was discharged on a tapering course of oral corticosteroids and was maintained on mesalamine. Follow-up endoscopy after a course of steroid therapy showed histologic remission in the colon, with improvement of the inflammation in the gastroduodenum, although a chronic diffuse coarse granular appearance remained [Figure 1O–Q]. Pathologic re-examination of gastroduodenum [Figure 1R and 1S] showed gastroduodenal lesion of UC in remission. Remission was still maintained with mesalamine in the 20-month follow-up. Our case is a rare occurrence that challenges the traditional Montreal classification of adult-onset UC, which does not include upper GI or small-bowel involvement. The present case might be a new phenotype of UC (i.e., UC with upper GI involvement) for several reasons: (1) The patient met the diagnostic criteria for colonic UC, with typical clinical manifestations, endoscopic and radiographic features and pathologic evidence (diffuse and continuous colitis), which ruled out CD, inflammatory bowel disease unclassified and indeterminate colitis; (2) the upper GI lesion in this patient was diagnosed with UC with upper GI involvement because of the good response to steroid therapy and its high similarity to colonic lesions in the endoscopic and macroscopic findings of the upper GI tract in the active inflammatory stage and especially in the remissive stage; (3) other common reasons for gastroduodenitis were excluded, including infectious and drug factors. The results of tests for serologic markers were positive for p-ANCA and were negative for ANCA, also suggested UC. This raises the question of whether upper GI involvement should be classified as a special and rare type of UC. Involvement of the upper GI tract and small intestine has been reported in adult-onset UC.[1–3] A previous study has also demonstrated that patients with UC and upper GI involvement may be at a higher risk for both extraintestinal manifestations and post-operative pouchitis.[4] As we know, the classification of adult-onset UC generally does not change to CD over time. However, the Montreal classification of UC in adults lacks of the subtype of UC with upper GI involvement. In contrast, the revised Porto classification of UC in children and adolescents from the European Society for Paediatric Gastroenterology Hepatology and Nutrition defines two categories of UC (typical and atypical), in which the presence of upper GI/small-bowel involvement is classified as atypical UC.[5] Taking insights from categories of UC in children and adolescents, it is worth considering if UC with upper GI involvement in adults should be classified as a separate disease subtype with a different disease course. Declaration of patient consent The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient has given his consent for his images and other clinical information to be reported in the article. The patient understands that his name and initials will not be published and due efforts will be made to conceal the identity of the patient, although anonymity cannot be guaranteed. Conflicts of interest None.

Gastric Crohn's Disease: A Rare Cause of Intermittent Abdominal Pain and Vomiting.

Differentiation of Isolated Small Bowel Crohn's Disease from Other Small Bowel Ulcerative Diseases: Clinical Features and Double-Balloon Enteroscopy Characteristics.

Is It a Case of Ileal Crohn’s Disease?

Is the Identification of Caseating Granuloma in the Intestine Indicative of Tuberculosis? a Rare Case of Crohn’s Disease

An analysis of histopathological features of Crohn’s disease in surgical specimens

P109 Analysis of the Clinical, Gastroscopic, and Pathological Features of Upper Gastrointestinal Lesions in Crohn’s Disease

A Combination of Pathological Features Identifies Crohn's Disease in Surgical Bowel Resection Specimens.

Is Adult-Onset Ulcerative Colitis Just Confined to Colon?

Mucosal Architectural Change is an Important Feature in Distinguishing Crohn's Disease from Others in Terminal Ileum Ulcer Biopsy

Atypical Presentation of Small Bowel Crohn's Disease: Case Report of Musculoskeletal and Hepatic Complications Without Gastrointestinal Symptoms

Microscopic Features of Small Bowel Mucosa of Patients with Crohn’s Disease

Gastric-like (pseudopyloric and pseudofoveolar) metaplasia and Paneth cell hyperplasia—neglected histological features of chronic ileal inflammation

Clinical and endosonographic features of gastroduodenal Crohn’s disease

Analysis of Clinical, Endoscopic, and Pathological Features of Upper Gastrointestinal Tract Lesions in Crohn's Disease

Recurrent Abdominal Distension: Colonic Ulcer is a Cause or a Consequence?

Intestinal wall thickness detected by multidetector spiral computed tomography enterography predicts the disease severity of Crohn's disease.

Granulomas As The Most Useful Histopathological Feature In Distinguishing Between Crohn'S Disease And Intestinal Tuberculosis In Endoscopic Biopsy Specimens

Conventional Ultrasound and Contrast-Enhanced Ultrasound in Evaluating the Severity of Crohn'S Disease

Differentiating Crohnʼs Disease from Intestinal Tuberculosis Using an Interferon Gamma Release Assay

NON-CASEATING GRANULOMAS ARE ASSOCIATED WITH STRICTURING CROHN’S DISEASE AND THEIR NUMBER AND SIZE ARE INCREASED IN THE MUSCULARIS PROPRIA OF STRICTURED COMPARED TO NON-STRICTURED INTESTINGAL SEGMENTS

Body Weight, Serum Albumin and Food Intolerance Were Linked to Upper Gastrointestinal Crohn's Disease: a 7-Year Retrospective Analysis